𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis

✍ Scribed by Giovanni Montini; Graziella Zacchello; Eugenio Baraldi; Stefania Zanconato; Agnese Suppiej; Fabrizio Fabris; Barbara Andreetta; Luigi Pavanello; Franco Zacchello


Book ID
117162440
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
447 KB
Volume
117
Category
Article
ISSN
1097-6833

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Recombinant human erythropoietin for the
✍ LeΓ³n, Pedro; JimΓ©nez, Miguel; Barona, Pascual; SierrasesΓΊmaga, Luis πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Background. Cancer is often associated with chronic anemia which frequently requires blood transfusions. This study was performed to assess the efficacy and safety of r-HuEPO therapy in children with cancer. Patients and methods. Twenty-five patients under 18 years of age with solid malignant